Overview
Chul Kim practices practicing medicine in Seoul, Republic of Korea.
Their clinical expertise encompasses Horner Syndrome, Cerebral Hypoxia, Neurofibromatosis Type 1 (NF1), and Neurofibromatosis.
They are actively involved in clinical research, co-authoring 29 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Chul H. Kim
Is Chul H. Kim a top-rated expert for Horner Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. Chul H. Kim is classified as an Experienced expert for Horner Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Chul H. Kim participate in research or clinical trials?
Yes. Chul H. Kim has published 29 articles and abstracts on conditions like Horner Syndrome. You can view a list of Chul H. Kim's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cerebral HypoxiaKim isExperienced. Learn about Cerebral Hypoxia.
- Eyelid DroopingKim isExperienced. Learn about Eyelid Drooping.
- Horner SyndromeKim isExperienced. Learn about Horner Syndrome.
- NeurofibromatosisKim isExperienced. Learn about Neurofibromatosis.
- Neurofibromatosis Type 1 (NF1)